发明授权
US09574001B2 Humanized single-chain antibody against beta 3 integrin for the treatment and prevention of metastasis
有权
针对β3整联蛋白的人源化单链抗体用于治疗和预防转移
- 专利标题： Humanized single-chain antibody against beta 3 integrin for the treatment and prevention of metastasis
- 专利标题（中）： 针对β3整联蛋白的人源化单链抗体用于治疗和预防转移
-
申请号： US13958145申请日： 2013-08-02
-
公开(公告)号： US09574001B2公开(公告)日： 2017-02-21
- 发明人: Thomas M. Wisniewski , Wei Zhang , Suying Dang
- 申请人： Thomas M. Wisniewski , Wei Zhang , Suying Dang
- 申请人地址： US NY New York
- 专利权人： New York University
- 当前专利权人： New York University
- 当前专利权人地址： US NY New York
- 代理机构： LeClairRyan, a Professional Corporation
- 主分类号： A61K39/395
- IPC分类号： A61K39/395 ; C07K16/28 ; A61K39/00
摘要：
The present invention relates to methods inhibiting tumor metastasis and treating cancer in a subject that involve administering to the subject an antibody which recognizes GPIIIa49-66, under conditions effective to inhibit tumor metastasis and/or treat cancer in the subject.
公开/授权文献
信息查询
